Keyphrases
Interferon-α (IFN-α)
100%
Acute Myeloid Leukemia
61%
Interferon Response
46%
Unc-51-like Kinase 1
39%
Myeloproliferative Neoplasms
39%
Interferon Signaling
37%
Mammalian Target of Rapamycin (mTOR)
36%
Stimulator of Interferon Genes (STING)
31%
Biological Response
30%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
26%
Type I Interferon
24%
Dual Targeting
24%
Type I Interferon Response
24%
Estrogen Receptor
24%
SLFN5
24%
Inhibitory Effect
24%
Leukemia
23%
Phosphorylation
23%
Type II Interferon
22%
Acute Myeloid Leukemia Cells
22%
Antileukemic Activity
22%
ULK1
21%
Type I Interferon Signaling
20%
Immune Response
18%
Autophagy
18%
Antitumor Immune Response
18%
Aberrant Crypt Foci
17%
Knock-in Mouse Model
16%
Signaling Pathway
16%
Immune Signaling
16%
Mitogen-activated Protein Kinase
16%
Regulatory Effect
16%
Tumor Microenvironment
15%
Therapeutic Approaches
15%
Antineoplastic Agents
14%
Antiviral Response
14%
Colon Adenocarcinoma
14%
Transcriptional Repressor
14%
Schlafen
14%
Interferon-γ
13%
Antiproliferative Activity
13%
Induced Expression
13%
Mucin Depleted Foci
12%
Mixed Lineage Kinase
12%
Tomivosertib
12%
SIN-1
12%
ERK5
12%
Mammalian Target of Rapamycin Pathway
12%
Regulatory Role
12%
Via Resistance
12%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
86%
Acute Myeloid Leukemia
61%
Phosphotransferase
44%
Myeloproliferative Neoplasm
37%
Estrogen Receptor
24%
Interferon Type I
19%
Antivirus Agent
19%
Knockout Mouse
16%
Neoplasm
14%
Colon Carcinogenesis
14%
Gamma Interferon
13%
Nanoshell
12%
Colitis
12%
Pancreas Adenocarcinoma
12%
Polyphenol
12%
Sirtuin
12%
Merestinib
12%
Mitogen Activated Protein Kinase 7
12%
Estrogen Receptor Beta
12%
Phosphatidylinositol 3 Kinase
12%
Chromatin Assembly Factor 1
12%
Mucin
12%
Cyclin Dependent Kinase 9
12%
Tomivosertib
12%
Mammalian Target of Rapamycin
12%
Mammalian Target of Rapamycin Complex 2
12%
Mixed Lineage Kinase 3
12%
Angiotensin Converting Enzyme 2
12%
Initiation Factor 4E
11%
Aberrant Crypt Foci
11%
Azoxymethane
8%
Colorectal Carcinoma
7%
Sirtuin 2
7%
Mitogen Activated Protein Kinase
6%
Anticarcinogen
6%
Leukemia
6%
Dextran Sulfate
6%
Medicine and Dentistry
Interferon
55%
Phosphotransferase
54%
Acute Myeloid Leukemia
37%
Myeloproliferative Neoplasm
26%
Initiation Factor 4E
23%
Mitogen-Activated Protein Kinase
19%
Antivirus Agent
14%
Gamma Interferon
13%
Leukemia Cell
13%
Mechanistic Target of Rapamycin
12%
Pancreas Adenocarcinoma
12%
Mammalian Target of Rapamycin Complex 2
12%
In Vitro
12%
Interferon Type I
12%
Mitogen Activated Protein Kinase 7
12%
Immune Checkpoint Inhibitor
12%
Merestinib
12%
Mixed Lineage Kinase 3
12%
Chromatin Assembly Factor 1
12%
Estrogen Receptor Beta
12%
Colitis
12%
Leukemia
12%
Neoplasm
12%
Estrogen Receptor
12%
Signal Transduction
12%
Interferon Receptor
6%
Melanoma
6%
Dextran Sulfate
6%
Anticarcinogen
6%
Colorectal Carcinoma
6%
RNA Translation
5%